Zosano Pharma Corp (ZSAN) Stock
ZSAN is no longer traded. Zosano Pharma was delisted from the Nasdaq in June 2022.
Prices on this page are historical; the last trade was June 10, 2022 at $0.56.
Zosano Pharma stock price history
ZSAN final trading statistics
- Final close
- $0.56
- Final trading day
- Jun 10, 2022
- Market cap at delisting
- $2.73M
- Shares outstanding
- 4.90M
- Final 52-week range
- $0.11 – $3.69
- Avg. volume (final 3 mo.)
- 7,926,906
- All-time high (split-adj.)
- $1000000.00 · Jan 2015
- All-time low (split-adj.)
- $0.52 · Jun 2022
- Return since IPO
- -100.0%
- Beta
- 3.29
- Book value / share
- $2.87
- Price / book
- 0.19
Zosano Pharma annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $785.0K | -$29.9M | -$2.32 |
| FY2020 | $224.0K | -$33.4M | -$0.57 |
| FY2019 | $0.00 | -$37.6M | -$2.34 |
| FY2018 | $0.00 | -$35.4M | -$6.44 |
| FY2017 | $0.00 | -$29.1M | -$18.00 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Zosano Pharma Corp
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Zosano Pharma stock FAQ
What happened to Zosano Pharma stock?
Zosano Pharma stock was delisted from the Nasdaq. Its final close was $0.56 on June 10, 2022.
Is ZSAN stock still trading?
No. ZSAN was delisted from the Nasdaq in June 2022 and no longer trades on a U.S. exchange.
What was the last price of ZSAN stock?
ZSAN closed at $0.56 on its final trading day, June 10, 2022, for a market value of about $2.73M.
What were Zosano Pharma's revenue and earnings in its last full fiscal year?
Zosano Pharma reported revenue of $785.0K and net income of -$29.9M in fiscal 2021, its last full year as a public company.
When did Zosano Pharma go public?
Zosano Pharma Corp stock began trading on January 27, 2015.